TOP TIERMARKET NEWSWIRE
SEC Form 4 history

DIANTHUS THERAPEUTIC (DNTH) insider trades

DIANTHUS THERAPEUTIC (DNTH) insider trading activity (SEC Form 4). Over the trailing 90 days, DNTH insiders filed 0 purchases totalling $0 and 5 sales totalling $26.0M — net SELLING of $26.0M. Most recent filing: Aug 7, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$26.0M
Net (90d)
-$26.0M
net selling
Most recent
Aug 7, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 7, 2026Garcia MarinoCEO, PresS SaleOE—$108.11$17.9Mfiling
Jul 13, 2026Savitz RyanEVP, CFO, CBOS SaleOE—$101.03$3.2Mfiling
Jun 18, 2026Veness Adam MSVP, GC, Sec.S SaleOE—$80.80$2.4Mfiling
Jun 2, 2026Randhawa SimratEVP, Head of R, DS SaleOE—$90.62$2.4Mfiling
May 11, 2026Soteropoulos PaulaDirS SaleOE—$85.47$51Kfiling